Alerts will be sent to your verified email
Verify EmailBALPHARMA
Bal Pharma
|
Smruthi Organics
|
Mangalam Drugs&Org.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.88 % | 3.58 % | 0.0 |
Financials
|
|||
5 yr Average ROE
|
1.96 % | 12.07 % | 7.15 % |
5yr average Equity Multiplier
|
4.59 | 1.54 | 2.25 |
5yr Average Asset Turnover Ratio
|
0.98 | 1.28 | 1.24 |
5yr Avg Net Profit Margin
|
-0.04 % | 6.02 % | 2.38 % |
Price to Book
|
2.0 | 2.12 | 0.94 |
P/E
|
21.44 | 42.58 | 20.77 |
5yr Avg Cash Conversion Cycle
|
41.77 Days | 70.37 Days | 51.34 Days |
Inventory Days
|
106.16 Days | 63.4 Days | 94.22 Days |
Days Receivable
|
104.16 Days | 105.63 Days | 27.67 Days |
Days Payable
|
132.37 Days | 96.18 Days | 84.69 Days |
5yr Average Interest Coverage Ratio
|
1.22 | 10.52 | 2.52 |
5yr Avg ROCE
|
15.4 % | 16.62 % | 15.15 % |
5yr Avg Operating Profit Margin
|
7.79 % | 12.47 % | 9.09 % |
5 yr average Debt to Equity
|
2.03 | 0.14 | 0.55 |
5yr CAGR Net Profit
|
n/a | -26.95 % | n/a |
5yr Average Return on Assets
|
0.43 % | 8.16 % | 3.55 % |
Shareholdings
|
|||
Promoter Holding
|
50.86 % | 64.73 % | 50.3 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 13.23 % |
Change in Promoter Holding (3 Yrs)
|
-1.14 % | 1.22 % | -0.12 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Bal Pharma
|
Smruthi Organics
|
Mangalam Drugs&Org.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|